Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD)

被引:0
|
作者
Gabhale, Sanjay D. [1 ]
Bagrecha, Mahavir Satishchand [2 ]
Dash, Mitali [3 ]
Sheikh, Zeeshan [4 ]
Bhuvaneshwari, S. [5 ]
Imran, Rangraze [6 ]
Satheesh, Tharini [7 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Resp Med, Pune, Maharashtra, India
[2] Dr DY Patil Med Coll Hosp & Res Ctr, Dept Pulm Med, Pune, Maharashtra, India
[3] SCB Med Coll, Dept Pathol, Cuttack, Odisha, India
[4] RD Gardi Med Coll, Ujjain, Madhya Pradesh, India
[5] KIIT Deemed Univ, Kalinga Inst Dent Sci, Bhubaneswar, Odisha, India
[6] RAK Med & Hlth Sci Univ, Dept Internal Med, Ras Al Khaymah, U Arab Emirates
[7] Dube Surg & Dent Hosp, AOMSI, Jabalpur, Madhya Pradesh, India
关键词
Chronic obstructive pulmonary disease; COPD; longitudinal research; pulmonary function; QoL; PREVENTION;
D O I
10.4103/jpbs.jpbs_252_24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition portrayed by persistent airflow limitation and correlated symptoms. Despite advances in treatment, COPD remains a significant global health burden, necessitating ongoing research to understand its long-standing impact on pulmonary function and quality of life (QoL). Methods: This longitudinal research enrolled 200 COPD and followed them over a 5-year period. Baseline assessments included spirometry to measure forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), along with standardized questionnaires assessing QoL. Follow-up assessments were conducted annually, and statistical analysis was performed to examine changes in pulmonary function and QoL over time. Results: Significant declines in FEV1 and FVC were observed at each follow-up time point compared to the baseline, indicating progressive deterioration in lung function. QoL scores, as assessed by the St. George's Respiratory Questionnaire and the COPD Assessment Test, also worsened progressively over the research period. Conclusion: Current conclusions underscore the progressive nature of COPD, highlighting the importance of proactive management strategies aimed at preserving lung function and improving QoL. Early intervention and ongoing monitoring are essential in optimizing outcomes for COPD subjects and reducing the disease burden on individuals and healthcare systems.
引用
收藏
页码:S2737 / S2739
页数:3
相关论文
共 50 条
  • [41] LONG-TERM PROGNOSIS OF POLYVASCULAR PATIENTS WITH ASSOCIATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Manea, Paloma
    Ghiuru, Rodica
    Gavrilescu, Maria Cristina
    Munteanu, D.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (03): : 669 - 673
  • [42] ABE assessment of chronic obstructive pulmonary disease (COPD) patients.
    Pandey, Anuj Kumar
    Verma, Ajay Kumar
    Kant, Surya
    Singh, Arpita
    Bajpai, Jyoti
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Effect of pulmonary rehabilitation nursing model on pulmonary function and quality of life in patients with stable chronic obstructive pulmonary disease
    Jiang, Yi
    Liu, Lin
    Jiang, Meifang
    MINERVA SURGERY, 2023, 78 (04): : 457 - 459
  • [44] Chronic Obstructive Pulmonary Disease (COPD) Quality Indicators
    Gershon, A. S.
    Mecredy, G.
    Camp, P.
    Hernandez, P.
    To, T. M.
    Tu, K.
    Aaron, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [45] The impact of treatment of chronic obstructive pulmonary disease (COPD) on functional status and quality of life of patients
    Tsavlis, Drosos
    Theodorou, Mamas
    Tzoumaka, Anna
    Lithoxopoulou, Hellie
    Minogiannis, Panagiotis
    Tsaousis, Vassilios
    Tektonidou, Anastasia
    Kaitelidou, Daphne
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Kostadinova, Vanya
    Radkov, Yordan
    Stoeva, Temenuga
    Miteva, Darina
    JOURNAL OF IMAB, 2020, 26 (03): : 3259 - 3266
  • [47] Long-term macrolide therapy in chronic obstructive pulmonary disease
    Parameswaran, Ganapathi Iyer
    Sethi, Sanjay
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : 1148 - 1152
  • [48] QUALITY OF LIFE AND ECONOMIC BURDEN AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN JAPAN
    Kubota, K.
    Igarashi, A.
    Saito, Y.
    Oyamada, M.
    Miyata, T.
    VALUE IN HEALTH, 2017, 20 (09) : A888 - A888
  • [49] Effect of cilomilast on chronic obstructive pulmonary disease (COPD) patients with impaired quality of life (QOL)
    Fischer, TL
    Borker, R
    Barnhart, F
    Morris, A
    Zhu, J
    CHEST, 2003, 124 (04) : 129S - 129S
  • [50] Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review
    Jo, Yong Suk
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (04) : 289 - 301